Home Categories API PD0332991 HCl
A4014412

PD0332991 HCl , ≥98% , 827022-32-2

Synonym(s):
6-Acetyl-8-cyclopentyl-5-methyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one, HCl, Cdk4/Cdk6 Inhibitor V, PD-0332991, HCl, PF-332991, HCl;StemSelect PD 0332991 - CAS 827022-32-2 - Calbiochem

CAS NO.:827022-32-2

Empirical Formula: C24H30ClN7O2

Molecular Weight: 483.994

MDL number: MFCD22420809

EINECS: 1592732-453-0

Pack Size Price Stock Quantity
5MG RMB239.20 In Stock
10MG RMB375.20 In Stock
50MG RMB1119.20 In Stock
100MG RMB1599.20 In Stock
250mg RMB2799.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

storage temp.  = -70C
solubility  ≥14.48 mg/mL in H2O; ≥2.42 mg/mL in DMSO; ≥2.79 mg/mL in EtOH with gentle warming and ultrasonic
form  Yellow liquid
color  Light yellow to yellow

Description and Uses

PD 0332991 is an orally active, selective inhibitor of the cyclin D kinases Cdk4 (IC50 = 11 nM) and Cdk6 (IC50= 16 nM) with no activity against a panel of 36 additional protein kinases. It has been reported to have antiproliferative activity against retinoblastoma-positive tumor cells, blocking retinoblastoma phosphorylation and inducing G1 arrest at nanomolar concentrations. PD 0332991 can inhibit the growth of certain ER-positive or HER2-amplified breast cancer cells (IC50s as low as 4 nM) and demonstrates synergy with tamoxifen and trastuzumab, respectively. PD 0332991 inhibition of Cdk4 activity has been used to demonstrate a role for insulin-activated cyclinD1-Cdk4 signaling in the control of glucose metabolism that is independent of cell cycle progression.

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H319
Precautionary statements  P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
HS Code  29399990

RELATED PRODUCTS